ArticleGlobalization and health2025
Commercial determinants of health: case study of ultra-processed food companies in Thailand.
Article in Globalization and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Shrinking appetites: Will GLP-1 adoption in high-income countries accelerate Big Food's push into low- and middle-income countries?Globalization and health · 2026Article
- Consumption of four unhealthy commodities and exposure to advertising, sponsorship, and promotion in Bamako, Mali.Health promotion international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUltra-processed food companies in Thailand have rapidly expanded, and they play an important role in the domestic economy and public policy. These companies influence policy-making by building networks with political authorities and using various strategies to pursue their interests. Increased consumption of ultra-processed foods has been shown to be strongly associated with obesity and other non-communicable diseases (NCDs), which are a growing public health concern in Thailand. This study investigated the commercial determinants of health (CDOH) strategies of the major ultra-processed food companies in Thailand.
methodsThis study employed document review to classify CDOH's strategies of ultra-processed food companies in Thailand. The authors searched publicly available information by 15 ultra-processed food companies, including both national and transnational companies, between January 2019 and December 2024. In addition, 30 semi-structured interviews were conducted with field experts to provide additional insights to support the findings from the document review. Thematic analysis was used to interpret the data.
resultsNational ultra-processed food companies in Thailand employ all seven strategies of CDOH, namely: (1) Political, (2) Scientific, (3) Marketing, (4) Supply chain and waste management, (5) Labour and employment, (6) Financial, and (7) Reputation management strategies. Transnational companies employed all but one of the seven strategies (labour and employment).
conclusionsThe wide array of CDOH strategies used to shape public policy and opinion may hinder efforts to protect the health of Thais from obesity and diet-related NCDs. To counter this, the authors recommend systematic monitoring of CDOH strategies, stronger accountability for the ultra-processed food companies, mandatory lobbyist registration, stricter management of conflict of interest between government officials and food companies, and strict enforcement of relevant legislation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.